Antiretroviral therapy coverage for PMTCT in Malaysia

Malaysia: Antiretroviral therapy coverage for PMTCT was 99.0% in 2024. ▲ Rising

Latest (2024)
99.0%
Change on year
unchanged
World rank
5th
of 84 countries
All-time high
99.0%
in 2000
All-time low
57.0%
in 2010
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Malaysia, 2000–2024

0204060801002000201220242000: 99 % of pregnant women living with HIV2001: 97 % of pregnant women living with HIV2002: 95 % of pregnant women living with HIV2003: 91 % of pregnant women living with HIV2004: 88 % of pregnant women living with HIV2005: 86 % of pregnant women living with HIV2006: 84 % of pregnant women living with HIV2007: 80 % of pregnant women living with HIV2008: 74 % of pregnant women living with HIV2009: 73 % of pregnant women living with HIV2010: 57 % of pregnant women living with HIV2011: 60 % of pregnant women living with HIV2012: 62 % of pregnant women living with HIV2013: 61 % of pregnant women living with HIV2014: 68 % of pregnant women living with HIV2015: 75 % of pregnant women living with HIV2016: 97 % of pregnant women living with HIV2017: 98 % of pregnant women living with HIV2018: 97 % of pregnant women living with HIV2019: 98 % of pregnant women living with HIV2020: 97 % of pregnant women living with HIV2021: 97 % of pregnant women living with HIV2022: 98 % of pregnant women living with HIV2023: 99 % of pregnant women living with HIV2024: 99 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

In 2024, antiretroviral therapy coverage for pmtct in Malaysia stood at 99.0%. That is the highest value across all 25 years on record.

That represents a change of up 45.6% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Malaysia peaked at 99.0% in 2000 and was at its lowest, 57.0%, in 2010.

That places Malaysia 5th out of 84 countries with data for 2024, putting it in the top 10%.

The long-run direction has been consistently rising across the 25 years of available data.

Antiretroviral therapy coverage for PMTCT in Malaysia, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Malaysia, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 99.0%
2001 97.0% -2.0%
2002 95.0% -2.1%
2003 91.0% -4.2%
2004 88.0% -3.3%
2005 86.0% -2.3%
2006 84.0% -2.3%
2007 80.0% -4.8%
2008 74.0% -7.5%
2009 73.0% -1.4%
2010 57.0% -21.9%
2011 60.0% +5.3%
2012 62.0% +3.3%
2013 61.0% -1.6%
2014 68.0% +11.5%
2015 75.0% +10.3%
2016 97.0% +29.3%
2017 98.0% +1.0%
2018 97.0% -1.0%
2019 98.0% +1.0%
2020 97.0% -1.0%
2021 97.0% +0.0%
2022 98.0% +1.0%
2023 99.0% +1.0%
2024 99.0% +0.0%

Malaysia compared with similar countries

  • Malaysia's 99.0% is above the median for upper middle income countries, which is 79.5%, 1.2× the median. (22 countries reporting)
  • Malaysia's 99.0% is above the median for East Asia & Pacific, which is 68.0%, 1.5× the median. (9 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Malaysia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2016 +29.3% 75.0% 97.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 86.7% 73.0% 99.0% 10
2010s 77.3% 57.0% 98.0% 10
2020s 98.0% 97.0% 99.0% 5

Countries ranked near Malaysia

  1. 5 Ghana 99.0% compare
  2. 5 Rwanda 99.0% compare
  3. 5 Tanzania 99.0% compare

See the full ranking of 99 places →

More health data for Malaysia

All data for Malaysia →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Malaysia?
Antiretroviral therapy coverage for pmtct in Malaysia was 99.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Malaysia?
The highest recorded value was 99.0% in 2000.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Malaysia?
The lowest recorded value was 57.0% in 2010.
How does Malaysia rank for antiretroviral therapy coverage for pmtct?
Malaysia ranks 5th out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Malaysia?
Over the last ten years it is up 45.6%. The long-run trend across the full record is rising.
Where does this Malaysia data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Malaysia. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/malaysia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/malaysia/">Antiretroviral therapy coverage for PMTCT in Malaysia</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).